| 股票代码 | 300529 | 当期评分 | ||||
| 股票名称 | 健帆生物 | |||||
| 报告日期 | 2018-12-31 | 2019-12-31 | 2020-03-31 | 2020-06-30 | 2020-09-30 | 2020-09-30 |
| 每股经营现金流(¥) | 0.9204 | 1.3937 | 0.3572 | 0.4252 | 0.6189 | ✘ |
| 销售净利润率(%) | 39.4434 | 39.7182 | 48.5238 | 50.5101 | 47.5709 | ✔ |
| 销售毛利率(%) | 82.9489 | 84.6339 | 84.1418 | 84.0212 | 84.3978 | ✔ |
| 净资产收益率(%) | 23.67 | 26.64 | 7.9 | 18.67 | 24.57 | ✘ |
| 营业增长率(%) | 41.4783 | 40.8566 | 28.3607 | 31.9994 | 35.4237 | ✔ |
| 净利润增长率(%) | 40.9537 | 41.8381 | 42.1147 | 43.9926 | 50.162 | ✔ |
| 每股收益(%) | 0.97 | 1.38 | 0.44 | 0.55 | 0.7887 | ✔ |
| 现金流量比率(%) | 137.712 | 222.1713 | 50.714 | 120.6959 | 211.3836 | ✔ |
| 三项费用比重(%) | 37.4928 | 36.8512 | 21.9489 | 23.6589 | 26.901 | ✔ |
| 每股净资产(¥) | 4.0704 | 5.1174 | 5.5731 | 2.9535 | 3.1952 | ✔ |
| 流动比率(%) | 4.68 | 5.9389 | 5.9313 | 6.0464 | 7.5072 | ✔ |
| 速动比率(%) | 4.4607 | 5.5874 | 5.6205 | 5.6957 | 6.9889 | ✔ |
| 现金比率(%) | 387.5251 | 484.223 | 366.5201 | 440.0854 | 440.0854 | ✔ |
| 总资产利润率(%) | 21.3589 | 25.0161 | 7.0593 | 16.8286 | 23.3313 | ✔ |
| 主营利润比重% | 178.2111 | 180.5209 | 147.494 | 141.1969 | 150.3872 | ✔ |
| 应收账款(万元) | 12,720.13 | 15,829.62 | 20,417.57 | 24,118.64 | 20,459.10 | ✔ |
| 应收票据(万元) | 1,050.80 | 236.81 | 811.25 | 5,511.74 | 6,290.26 | ✘ |
| 预付款项(万元) | 2,038.07 | 2,437.98 | 4,573.17 | 3,842.25 | 4,515.93 | ✔ |
| 存货(万元) | 6,115.76 | 9,231.40 | 9,167.31 | 9,875.13 | 12,125.89 | ✔ |
| 在建工程(万元) | 2,957.19 | 9,174.12 | 11,697.03 | 14,980.89 | 20,063.15 | ✔ |
| 应付款项(万元) | 2,989.72 | 3,283.11 | 3,683.78 | 3,707.42 | 4,400.36 | ✘ |
| 长期借款(万元) | -- | -- | -- | -- | -- | ✔ |
| 未分配利润(万元) | 69,661.92 | 95,867.03 | 114,309.55 | 102,149.08 | 120,827.17 | ✔ |
| 商誉(万元) | 4,407.01 | 4,407.01 | 4,407.01 | 4,407.01 | 4,407.01 | ✔ |
| 流动资产(万元) | 74,671.62 | 93,491.84 | 96,482.65 | 102,354.59 | 111,264.67 | ✘ |
| 流动负债(万元) | 27,889.86 | 26,263.31 | 29,490.71 | 28,154.77 | 23,396.77 | ✔ |
健帆生物300529评分结果 | 78.79分 | 买入/增持 | ||||